Operating Lease, Liability, Noncurrent of Intra-Cellular Therapies, Inc. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Intra-Cellular Therapies, Inc. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 31 Dec 2024 was $12,748,000, a 4.3% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $12,748,000 -$578,000 -4.3% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $13,506,000 -$385,000 -2.8% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $14,117,000 -$315,000 -2.2% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $12,737,000 -$2,224,000 -15% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $13,326,000 -$2,148,000 -14% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $13,891,000 -$5,276,000 -28% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $14,432,000 -$4,643,000 -24% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $14,961,000 -$1,795,000 -11% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $15,474,000 -$3,201,000 -17% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $19,167,000 -$1,156,918 -5.7% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $19,075,000 -$2,613,851 -12% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $16,756,000 -$5,881,100 -26% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $18,675,000 -$4,925,347 -21% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $20,323,918 -$3,545,639 -15% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $21,688,851 +$530,610 +2.5% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $22,637,100 +$2,919,077 +15% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $23,600,347 +$3,645,161 +18% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $23,869,557 +$3,599,911 +18% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $21,158,241 +$590,476 +2.9% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $19,718,023 -$1,141,066 -5.5% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $19,955,186 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $20,269,646 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $20,567,765 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $20,859,089 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.